Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_assertion type Assertion NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_head.
- NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_assertion description "[ADAM9 is overexpressed in prostate cancer cases and is an independent prognostic marker of PSA relapse-free survival following radical prostatectomy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_provenance.
- NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_assertion evidence source_evidence_literature NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_provenance.
- NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_assertion SIO_000772 18061337 NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_provenance.
- NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_assertion wasDerivedFrom lhgdn-20090331 NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_provenance.
- NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_assertion wasGeneratedBy ECO_0000203 NP103932.RAZ12TZt25kBpcbSsz0a_Qbh_5VF-e8kLzkQ-zdIKyxE4130_provenance.